CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects.
Sakai T, Aoyama N, Kita T, Sakaeda T, Nishiguchi K, Nishitora Y, Hohda T, Sirasaka D, Tamura T, Tanigawara Y, Kasuga M, Okumura K.
Sakai T, et al. Among authors: sakaeda t.
Pharm Res. 2001 Jun;18(6):721-7. doi: 10.1023/a:1011035007591.
Pharm Res. 2001.
PMID: 11474773
Clinical Trial.